Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Directly observed versus self-administered sulphadoxine-pyrimethamine for malaria prevention in antenatal women
PACTR202511764498401Not yet recruiting
- Sponsor
- ONI OLUWATOBI STEPHEN
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by ONI OLUWATOBI STEPHEN. Primary endpoints: Prevalence of peripheral parasitaemia at delivery and Cord malaria at delivery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202511764498401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511764498401.